CVS Caremark Corporation Kicks Its Habit, and Its Name

CVS Caremark (NYSE: CVS  ) , the second-largest U.S. pharmacy chain, has a lot on its plate. Not only is the company tossing tobacco from its stores, it's also changing its corporate name to CVS Health.

The move reflects a shift throughout the pharmacy industry that de-emphasizes general merchandise and focuses instead on health services such as counseling patients with chronic diseases and treating patients with the flu.

CVS Health has been at the forefront of this changing business model, arguably outpacing rivals Walgreen  (NASDAQ: WBA  ) and Rite Aid (NYSE: RAD  ) . So let's learn more about CVS' decision and what it may mean for the industry.

Source: CVS Health

Expanding directions
CVS launched its first in-store healthcare clinic in 2000, and that pilot program has turned into a massive network that totals more than 850 MinuteClinic locations that have served more than 21 million patients.

Those in-store clinics are increasingly offering more services, expanding far beyond immunizations in a bid to supplement primary care.

Demand for these clinics, which stay open longer each day than a typical physician's office, continues to increase as insurers and other healthcare payers recognize clinics' ability to lower medical costs via fixed prices that significantly undercut emergency room care. As a result, CVS Health reported that MinuteClinic sales jumped 24% year-over-year in the second quarter.

However, CVS' previous front-of-store reliance on tobacco product sales marked a big disconnect from its expansion into improving the health of its customers. According to the U.S. surgeon general, more than 20 million Americans have died prematurely from smoking-related illness since 1965.

Source: CVS Health.

Knowing where you're going
It's tough to get where you're going if you don't have a destination, and that's likely a big reason CVS has decided to ditch "Caremark" from its name and replace it with "Health."

The CVS Caremark name served the company well following its acquisition of Caremark, a pharmacy benefit manager, or PBM, that manages prescription programs for insurers and other healthcare payers.

Acquiring Caremark significantly expanded CVS' reach, turning it into a national business less reliant on local stores. Today, sales at CVS Health's PBM operation eclipse $76 billion, and its business mission has similarly shifted to a more holistic approach to patient health.

Some PBMs are increasingly positioning themselves as patient health counselors rather than cost-crunching negotiators. That's an important shift given that counseling patients to improve adherence to medicine reduces the likelihood of debilitating (and expensive) hospitalizations.

Fool-worthy final thoughts
CVS Health isn't just eliminating tobacco products from its stores; it's also launching a massive marketing push to help its customers quit.

The company's "Let's Quit Together" program encourages tobacco users to visit MinuteClinics for personalized smoking cessation recommendations, or to discuss tips on ending tobacco use with CVS pharmacists. CVS has even created a Web survey that allows visitors to measure their nicotine dependence. 

Those services may resonate and encourage patient interactions that would dovetail nicely with CVS Health's increasingly care-focused mission. Offering this and additional patient-focused healthcare may help insulate its business from rivals such as Walgreen, Rite-Aid, and even Wal-Mart, which are also increasingly embracing primary care-oriented services.

Leaked: The next revolutionary healthcare opportunity
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3090116, ~/Articles/ArticleHandler.aspx, 8/31/2015 6:56:04 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Todd Campbell

Todd has been helping buy side portfolio managers as an independent researcher for over a decade. In 2003, Todd founded E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors. Todd has provided insight to a variety of publications, including SmartMoney, Barron's, and CNN/fn.

Today's Market

updated 2 days ago Sponsored by:
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 1.21 0.06%
NASD 4,828.33 15.62 0.32%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/28/2015 4:01 PM
CVS $104.18 Down -1.02 -0.97%
CVS Health CAPS Rating: ****
RAD $8.24 Down +0.00 +0.00%
Rite Aid Corp CAPS Rating: ***
WBA $87.42 Down -0.43 -0.49%
Walgreen Boots All… CAPS Rating: ****